Free Trial

Phio Pharmaceuticals (PHIO) Institutional Ownership

Phio Pharmaceuticals logo
$1.07 -0.07 (-6.14%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$1.09 +0.02 (+1.87%)
As of 05/8/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Phio Pharmaceuticals (NASDAQ:PHIO)

Current
Institutional Ownership
Percentage
57.31%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$83.77K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$14.10K
Get PHIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Phio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PHIO Institutional Buying and Selling by Quarter

Phio Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2026Cetera Investment Advisers42,500$45K0.0%+26.9%0.395%
2/9/2026Geode Capital Management LLC92,638$97K0.0%+60.0%0.861%
8/8/2025Cetera Investment Advisers32,500$76K0.0%-15.6%0.677%
8/8/2025Geode Capital Management LLC57,694$136K0.0%+38.7%1.202%
2/11/2025Virtu Financial LLC40,910$74K0.0%N/A0.594%
8/14/2023Anson Funds Management LP22,571$65K0.0%N/A1.505%
8/10/2023Cetera Investment Advisers10,666$31K0.0%N/A0.711%
8/2/2023Bank of Montreal Can10,000$38K0.0%N/A0.667%
8/11/2022Cetera Investment Advisers75,000$53K0.0%-16.7%0.549%


PHIO Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Phio Pharmaceuticals shares: Geode Capital Management LLC ($97K), and Virtu Financial LLC ($74K), Cetera Investment Advisers ($45K).Learn more on Phio Pharmaceuticals' institutional investors.

57.31% of Phio Pharmaceuticals' stock is owned by institutional investors. Learn more on PHIO's institutional investor holdings.

The following institutional investors have purchased Phio Pharmaceuticals' stock in the last 24 months: Geode Capital Management LLC ($50.84K), Virtu Financial LLC ($40.91K), and Cetera Investment Advisers ($9K).

Institutional investors have bought a total of 59,840 shares in the last 24 months. This purchase volume represents approximately $83.77K in transactions.

The following institutional investors have sold Phio Pharmaceuticals stock in the last 24 months: Cetera Investment Advisers ($6K).

Institutional investors have sold a total of 6,000 shares in the last 24 months. This volume of shares sold represents approximately $14.10K in transactions.



This page (NASDAQ:PHIO) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners